ecancermedicalscience

Short Communication

Essential considerations in the investigation of associations between insulin and cancer risk using prescription databases

11 Dec 2009
P Boyle, I Ford, JFR Robertson, C La Vecchia, P Boffetta, P Autier

Studies of disease outcomes using administrative databases have identified a number of problems with the approach that suggest the need for a high level of expertise in their conduct. This is particularly true in the case of the investigation of the role of different insulins and the risk of cancer, which poses particular issues addressed below.

Related Articles

Clara Pierini, Clara Mariano y Jelicich, Fabiola Bascuñán Acuña, María De San Martín, Aldana Casati, Cecilia Casullo, Marta Díaz Madero, Delfina Grennon Viel, Estefania Marzik, Gabriela Rodriguez, Victoria Viel Temperley
Ochomo Edwin Onyango, Philiph Tonui, Peter Itsura, Elkanah Omenge Orang'o, Kapten Muthoka, Sayo Loice, Benard Ochieng Samba, Barry Rosen, Patrick Loehrer, Susan Cu-Uvin
Marco Aurélio Bertúlio das Neves, Noemi Dreyer Galvão, Fernanda Cristina da Silva de Lima, Júlio Fernando Pinto Oliveria, Sancho Pedro Xavier, Ageo Mário Cândido da Silva
Carlos Gómez Calcetero, Juanita Granados Diaz, Adriana Aya Porto, Andres Forero Romero, Maria López Mora, Paola Omaña Orduz, Jorge Daza Buitrago, Maira Murcia Linares, Viriginia Abello Polo
Parth Sharma Harsh Thakkar, Aryan Patil, Preeti Chauhan, Priya Chembon, Shalini Arora Joseph, Smriti Rana, Raj Kalady, Vidhi Wadhwani, Gaurav Urs, Padmavathy Krishna, Rontu Sangma, Rajendra Dutt Bijalwan, Sunanda Samal, Lalit Selvaraju, Syed Mohammad Askari Naqvi, Jatin Bhukal, Johnsurya John, Muttacaud Ramakrishnan Rajagopal, Siddhesh Zadey